Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.11.24
/
50%
€470.80
Target price
14.11.25
€545.96
Performance (%)
-19.47%
End price
15.11.25
€379.15
Summary
This prediction ended on 15.11.25 with a price of €379.15. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -19.47%. Citigroup_Inc_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.412% | 2.412% | -6.387% |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% |
Comments by Citigroup_Inc_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
19.49%
13.02.26
13.02.26
